Medical Marijuana for Post-Surgical Pain in Florida
Persistent pain following surgical procedures that does not resolve with standard treatment.
Medically reviewed by Bruce Stratt, MD
Board-Certified Physician · OMMU Certified · Boca Raton, FL
Overview
Chronic post-surgical pain (CPSP) is defined as pain that persists beyond the normal healing period — typically three months or longer after a surgical procedure. It affects an estimated 10–50% of patients following common surgeries including joint replacements, spinal procedures, mastectomies, thoracotomies, cardiac bypass, and hernia repairs. CPSP can involve neuropathic pain (nerve damage), inflammatory pain, or both, and often does not respond well to the same analgesics that managed acute post-operative pain.
The conventional approach to managing CPSP typically involves opioids, gabapentinoids, and nerve blocks. However, long-term opioid use for post-surgical pain is a significant driver of the opioid dependency crisis — research shows that approximately 6% of surgical patients who receive opioids develop persistent use. Many patients become trapped in a cycle of escalating opioid doses with diminishing returns and mounting side effects, making alternative pain management approaches critically important.
Post-surgical pain qualifies for medical marijuana in Florida under the chronic pain provision of Statute 381.986. For patients facing elective surgery, establishing a medical marijuana certification before the procedure allows cannabis to be incorporated into the perioperative pain management plan from the outset — research shows the best opioid-sparing results come from beginning cannabis before surgery rather than after opioid dependence has already developed.
How Medical Cannabis May Help
Medical cannabis addresses post-surgical pain through multiple mechanisms — reducing inflammation at the surgical site, modulating neuropathic pain signals, relieving muscle tension around the affected area, and improving sleep quality essential for tissue healing. A randomized trial at Northwest Medical Center (Hackett et al., Cureus, 2024) found that patients undergoing coronary artery bypass graft (CABG) surgery who received dronabinol (synthetic THC) alongside standard opioids experienced a 40% reduction in postoperative opioid requirements and greater improvement in cardiac function compared to the opioid-only control group. Cannabinoids interact with the same pain pathways as opioids but through different receptor systems — CB1 receptors in the periaqueductal gray and dorsal horn modulate both ascending pain signals and descending inhibitory pathways. When combined with opioids, this creates additive or synergistic pain relief at lower doses of each, potentially reducing the risk of opioid dependence. The landmark Boehnke et al. study (2016) found a 64% decrease in opioid use and 45% improvement in quality of life among chronic pain patients using medical cannabis. Cannabis also addresses the anxiety and depression that frequently accompany chronic pain, and its anti-inflammatory properties (via CBD's action on CB2 receptors and inhibition of TNF-alpha and IL-6) may support ongoing tissue healing. Dr. Stratt will evaluate your post-surgical pain and create an individualized treatment plan, coordinating with your surgeon when appropriate. For patients with upcoming surgeries, proactive planning allows cannabis to be integrated from the perioperative period.
Individual results vary. Consult with Dr. Stratt to understand how cannabis therapy may apply to your specific situation.
What to Bring to Your Appointment
Bring a valid Florida ID and surgical records, post-operative notes, current pain management documentation, and imaging reports if relevant.
Frequently Asked Questions
Related Articles
Patient Resources
Get Your Medical Marijuana Card for Post-Surgical Pain
Schedule your evaluation with Dr. Stratt. Same-day state registry submissions for qualifying patients.